1 of 1

  • Aerobic exercise
    • Increased flow of oxygen-rich blood to the brain and improved overall health of the blood vessels - improves brain function
  • Creative therapy
    • Reduce agitation and increased brain stimulation
  • Meditation and music
    • Boost mood, stimulate positive interactions, facilitate cognitive function
    • Evokes memory and emotion
  • Brexpiprazole
    • Effective in reducing agitation for AD
  • Levetiracetam
    • Low-dose was well tolerated in AD patients
    • Enhanced spatial memory and executive functioning tasks
  • Methylphenidate
    • methylphenidate treatment led to a modest but noticeable reduction in apathy among patients with AD, as measured by the NPI apathy subscale

Alzheimer’s disease (AD), a brain disorder that impairs cognitive functions, is the fifth-leading cause of death among adults over 65 and the sixth-leading cause of death for all adults in the US. Although the exact causes of AD are unknown, it is currently characterized by two abnormalities in the brain: amyloid plaques and neurofibrillary tangles which lead to neuronal degradation. This results in slower communication between cells and therefore slower mental processes: usually dementia and language impairment. Although it is so prevalent, AD is still incurable, but there are many novel treatments currently under research.

Introduction

Non-pharmacological

Medication

  • rTMS
    • Electromagnetic coil placed at the scalp of the patient’s head - sends magnetic pulses that stimulate neurons
    • Slow down cognitive and functional decline
  • tACS
    • Delivers a gentle, sinusoidal electrical current to the brain via electrodes on scalp
    • Improved episodic memory
  • DBS
    • Electrodes implanted in areas of the brain
    • Hippocampus volume increased - 12 month

Neuromodulation

Brexpiprazole

Methylphenidate

Levetiracetam

rTMS

tACS

DBS

References

Novel Treatments for Alzheimer’s Disease

Diya Dipak